These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 33404854

  • 1. Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.
    Terasaki M, Terasaki Y, Wakamatsu K, Kuwahara N, Yoneyama K, Kawase R, Kurose K, Toda E, Endo Y, Kunugi S, Kajimoto Y, Shimizu A.
    Virchows Arch; 2021 May; 478(5):893-904. PubMed ID: 33404854
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Histochemical assessment of osteoclast-like giant cells in Rankl-/- mice.
    Miyamoto Y, Hasegawa T, Hongo H, Yamamoto T, Haraguchi-Kitakamae M, Abe M, Maruoka H, Ishizu H, Shimizu T, Sasano Y, Udagawa N, Li M, Amizuka N.
    J Oral Biosci; 2023 Jun; 65(2):175-185. PubMed ID: 37088151
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.
    Byon CH, Sun Y, Chen J, Yuan K, Mao X, Heath JM, Anderson PG, Tintut Y, Demer LL, Wang D, Chen Y.
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1387-96. PubMed ID: 21454810
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.
    Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF.
    J Biol Chem; 2007 Jun 22; 282(25):18245-18253. PubMed ID: 17485464
    [Abstract] [Full Text] [Related]

  • 14. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
    Liu B, Yu SF, Li TJ.
    J Oral Pathol Med; 2003 Jul 22; 32(6):367-75. PubMed ID: 12787044
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S, Omori K, Nakayama M, Mandai H, Yamamoto S, Kobayashi H, Sako H, Sakaida K, Yoshimura H, Ishii S, Ibaragi S, Hirai K, Yamashiro K, Yamamoto T, Suga S, Takashiba S.
    Int Immunopharmacol; 2020 Jun 22; 83():106429. PubMed ID: 32222639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
    Odkhuu E, Koide N, Haque A, Tsolmongyn B, Naiki Y, Hashimoto S, Komatsu T, Yoshida T, Yokochi T.
    Immunol Lett; 2012 Feb 29; 142(1-2):34-40. PubMed ID: 22193059
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.